State Key Laboratory of Cardiovascular Medicine, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
J Cardiothorac Vasc Anesth. 2013 Apr;27(2):305-11. doi: 10.1053/j.jvca.2012.09.028. Epub 2012 Dec 29.
Clinical trials on cardioprotection by remote ischemic preconditioning (RIPC) for adult patients undergoing cardiac surgery revealed mixed results. Previous meta-analyses have been conducted and found marked heterogeneity among studies. The aim of this meta-analysis was to evaluate the factors affecting cardioprotection by remote preconditioning in adult cardiac surgery.
A meta-analysis of randomized controlled trials.
University hospitals.
Adult subjects undergoing cardiac surgery.
RIPC.
Fifteen trials with a total of 1,155 study patients reporting postoperative myocardial biomarker (CK-MB or troponin) levels were identified from PubMed, Embase, and the Cochrane Library (up to July 2012). Compared with controls, RIPC significantly reduced postoperative biomarkers of myocardial injury (standardized mean difference = -0.31, p = 0.041; heterogeneity test: I(2) = 83.5%). This effect seemed more significant in valve surgery (standardized mean difference = -0.74, p = 0.002) than in coronary artery surgery (standardized mean difference = -0.23; p = 0.17). Univariate meta-regression analyses suggested that the major sources of significant heterogeneity were β-blockers (%) (coefficient = 0.0161, p = 0.022, adjusted R(2) = 0.37) and volatile anesthetics (coefficient = 0.6617, p = 0.065, adjusted R(2) = 0.22). These results were further confirmed in multivariate regression and subgroup analyses.
Available data from this meta-analysis further confirmed the cardioprotection conferred by RIPC in adult cardiac surgery. Moreover, the cardioprotective effect may be attenuated when combined with β-blockers or volatile anesthetics.
针对接受心脏手术的成年患者的远程缺血预处理(RIPC)的心脏保护作用的临床试验结果不一。先前已进行了一些荟萃分析,发现这些研究之间存在显著的异质性。本荟萃分析的目的是评估影响成人心脏手术中远程预处理心脏保护作用的因素。
随机对照试验的荟萃分析。
大学医院。
接受心脏手术的成年患者。
RIPC。
从 PubMed、Embase 和 Cochrane 图书馆(截至 2012 年 7 月)检索到 15 项试验,这些试验共纳入了 1155 例报告术后心肌生物标志物(CK-MB 或肌钙蛋白)水平的研究患者。与对照组相比,RIPC 显著降低了术后心肌损伤的生物标志物(标准化均数差=-0.31,p=0.041;异质性检验:I(2)=83.5%)。这种作用在瓣膜手术中(标准化均数差=-0.74,p=0.002)似乎比在冠状动脉手术中(标准化均数差=-0.23;p=0.17)更显著。单变量荟萃回归分析表明,显著异质性的主要来源是β受体阻滞剂(%)(系数=0.0161,p=0.022,调整 R(2)=0.37)和挥发性麻醉剂(系数=0.6617,p=0.065,调整 R(2)=0.22)。这些结果在多变量回归和亚组分析中得到进一步证实。
本荟萃分析的现有数据进一步证实了 RIPC 对成人心脏手术的心脏保护作用。此外,当与β受体阻滞剂或挥发性麻醉剂联合使用时,这种保护作用可能会减弱。